Skip to main content

Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay.

Waddell N, Cocciardi S, Johnson J, Healey S, Marsh A, Riley J, da Silva L, Vargas AC, Reid L, Simpson PT, Lakhani SR, Chenevix-Trench G

Publication: J Pathol (2010) • Vol 221 • Page 452-61PMID: 20593485View on PubMed

Purpose

The purpose of this paper was to determine the effects of storage and using formalin-fixed paraffin-embedded (FFPE) instead of frozen breast tumor specimens on cDNA-mediated Annealing, Selection, Extension, and Ligation (DASL) assay success and results.

Conclusion

While some of the FFPE specimens stored for more than 7 years failed DASL quality control, all of the specimens stored less than 7 years passed DASL quality control. Real-time qRT-PCR cycle threshold (CT) values, RNA fragment size (by bioanalyzer) and RNA integrity numbers (RIN) did not predict DASL success, but average CT values using TaqMan assays were higher and RNA concentrations were lower for specimens that failed DASL quality control than those that passed. DASL data from technical replicates of FFPE specimens were very strongly correlated, but these correlations were weaker than those observed for technical replicates of frozen specimens. Using a gene-list of 240 transcripts, 12/15 FFPE specimens were assigned to the same cancer subtype as the frozen counterpart. Importantly, in 1 of 8 FFPE specimens that had technical replicates, the replicates were assigned to different subtypes.

Studies (1)

Purpose

The purpose of this study was to determine the effects of storage and using FFPE instead of frozen breast tumor specimens on DASL assay success and results. Tumor cells were microdissected from 2-20 freshly cut sections and lysed in proteinase K before extraction of RNA with Tri Reagent.

Summary of Findings

93% of the 92 FFPE specimens yielded sufficient RNA to use in the DASL assay, and 85% of the 101 specimens (including duplicates) passed DASL quality control. Interestingly, RNA from 7 of the 15 specimens that did not produce data of sufficient quality was arrayed in duplicate and worked in the replicate specimen. While some of the FFPE specimens stored 7 years or more failed DASL quality control, all of the specimens stored less than 7 years passed DASL quality control. Real-time qRT-PCR CT values, RNA fragment size (by bioanalyzer) and RIN did not predict DASL success, but average CT values using TaqMan assays were higher and RNA concentrations were lower for specimens that failed DASL quality control than those that passed. Technical replicates of FFPE specimens yielded DASL data that was very strongly correlated (r2=0.90-0.98), but these correlations were weaker than those observed between technical replicates of frozen specimens (r2=0.98-0.99). Importantly 3565 of 18,227 probes produced discordant data between technical replicates in at least 4 of 8 specimens for which replicates were available. Using a gene-list of 240 transcripts 12/15 FFPE specimens were assigned to the same cancer subtype as the frozen counterpart. Importantly, in 1 of 8 FFPE specimens that had technical replicates, the replicates were assigned to different subtypes.

  • Biospecimens

    TissueBreast
  • Preservation Types

    FrozenFormalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    RNADASL
    RNAReal-time qRT-PCR
    RNAAutomated electrophoresis/Bioanalyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen PreservationType of fixation/preservation
    Formalin (buffered)
    Frozen
    StorageStorage duration
    <7 years
    > 7 years
    Real-time qRT-PCR SpecificDetection method
    SYBR
    TaqMan probes
    Real-time qRT-PCR SpecificTargeted nucleic acid
    RPL13A